The FCC and HHS – two of the Federal Agencies tasked with enforcing privacy regulations in the US – have been called on the carpet for not doing so.

/in /by

On the same day.  FCC.2019.11.8. Letter re Location Privacy and HHS Ltr from Senator Warner 8NOV2019  

Read more

Tech Center 1700 PTAB Observations, October 2019

/in , /by

As due diligence for an appeal in a difficult case I have been prosecuting for a client, I looked through the decisions issued by PTAB out of Tech Center 1700 in October of 2019.  Here are some things I found interesting: The Board heard 80 appeals, and reversed the Examiner 24 times. In the reversals: […]

Read more

Things go from bad to worse for L’Oreal in their multifaceted litigation with Olaplex

/in , , , /by

In 2018, the Federal Circuit reversed the District Court of Delaware’s refusal to grant Liqwd a preliminary injunction against L’Oreal Liqwd v L’Oreal Preliminary Injunction.  Many reported earlier this summer on L’Oreal’s expensive loss to Olaplex in the District Court of Delaware.  (See, e.g., https://www.bloomberg.com/news/articles/2019-08-12/l-oreal-owes-startup-91-million-for-stealing-its-trade-secrets).  L’Oreal has now been dealt another blow by the Federal […]

Read more

Federal Circuit reverses PTAB’s holding that the preamble “travel trailer” was nothing more than an intended use, and not limiting

/in /by

David Fought and Martin Clanton (“Appellants”, In re Fought and Clanton) are the named inventors on US Patent Application No. 13/507528 directed to a “travel trailer.”  The Examiner rejected the claim 1 under 35 USC 102(b) over a reference describing a conventional truck trailer and claim 2 under 35 USC 102(b) over a reference describing […]

Read more

UK Court Holds “Consisting Essentially of” Language does not give Rise to “Objectionable Uncertainty”

/in , /by

Anan Kasei v Neo Chemicals Though the claims at issue in this UK infringement action recited properties that could be deemed to be the claimed oxide’s “essential characteristics,” it is interesting to compare this case with HZNP v. Horizon Pharma (see my recent post for further details), recently decided by the Federal Circuit. The UK […]

Read more

Federal Circuit holds that transitional phrase “consisting essentially of” renders claim indefinite, unless the “basic and novel properties” of the invention are definite

/in , /by

HZNP Medicines LLC, Horizon Pharma USA Inc., v. Actavis Laboratories UT, Inc., HZNP v Horizon Pharma Appeal No. 2017-2149 et al, decided October 10, 2019 was an appeal from the District Court of New Jersey’s judgment of invalidity and noninfringement.  Amongst others, at issue was the District Court’s construction of the transitional phrase “consisting essentially […]

Read more